Context and objectives
Immerse a senior delegation from a leading global pharmaceutical group in the CES 2025 innovation ecosystem, identify breakthrough health-tech start-ups and corporate partners, and translate CES insights into a concrete innovation and partnership roadmap aligned with the client's priorities in digital health, AI and consumer health.
Outcome
- A prioritised post-CES action plan covering more than 10 start-up partnership opportunities, with clear rationale, next steps and owners.
- Four high-priority corporate partnership tracks directly supporting the client's data strategy, clinical trial acceleration and AI-powered patient monitoring ambitions.
- Recommendations validated by executive committee sponsors, with first follow-up meetings initiated after CES.
Our approach
- End-to-end curation of a three-day innovation tour across four verticals (digital health, AI, health and wellness, food tech), with an itinerary tailored to the client's areas of interest and R&D agenda.
- Scouting and in-depth assessment of more than 40 companies, including over 20 start-ups, with structured briefings and live meetings facilitated by Emerton Data experts.
- Attendance and synthesis of four strategic panels (Health AI 2030, Future of Health, Digital Health Frontier, Personalized Medicine), with C-suite speakers from leading technology, pharmaceutical and medtech companies.
- Targeted one-on-one meetings with senior executives from several companies.
Other case studies
All case studies- Digital transformation of a global leader's R&D Launching and ramping up the data and AI programme of a global food leader's R&I division Read the case study →
- Data and digital organisational benchmark for R&I How competitors and comparable players organise data and digital in R&D, for a food industry leader Read the case study →
- R&D process optimisation Re-engineering the R&D organisation of a B2B energy services provider Read the case study →